Inspire Medical Systems, Inc. Common Stock (INSP)
92.86
-0.19 (-0.20%)
NYSE · Last Trade: Aug 21st, 11:20 AM EDT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 21, 2025
RADNOR, PA - August 21, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of Inspire Medical Systems, Inc. ( NYSE: INSP ) (“Inspire”).
Via TheNewswire.com · August 21, 2025
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Nutex Health Inc. (NASDAQ:NUTX), Anika Therapeutics, Inc. (NASDAQ:ANIK), Fluor Corporation (NYSE:FLR), and Inspire Medical Systems, Inc. (NYSE:INSP). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · August 20, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 20, 2025
RADNOR, PA - August 20, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of Inspire Medical Systems, Inc. ( NYSE: INSP ) (“Inspire”).
Via TheNewswire.com · August 20, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 20, 2025
NEW YORK, NY - August 20, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Inspire Medical Systems. (“Inspire” or the “Company”) (NYSE: INSP).
Via TheNewswire.com · August 20, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 18, 2025
NEW YORK, NY - August 18, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Inspire Medical Systems. (“Inspire” or the “Company”) (NYSE: INSP).
Via TheNewswire.com · August 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 15, 2025
RADNOR, PA - August 15, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of Inspire Medical Systems, Inc. ( NYSE: INSP ) (“Inspire”).
Via TheNewswire.com · August 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 15, 2025
NEW YORK, NY - August 15, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Inspire Medical Systems. (“Inspire” or the “Company”) (NYSE: INSP).
Via TheNewswire.com · August 15, 2025
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”).
By Kessler Topaz Meltzer & Check, LLP · Via Business Wire · August 14, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire (INSP) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · August 12, 2025
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 9, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire (INSP) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · August 7, 2025
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · August 5, 2025

NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (NYSE: INSP) on behalf of long-term stockholders following a class action complaint that was filed against Inspire Medical on December 22, 2023 with a Class Period from May 3, 2023 to November 7, 2023. Our investigation concerns whether the board of directors of Inspire Medical have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · July 17, 2024

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.
Via MarketBeat · July 1, 2024

NEW YORK, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (NYSE: INSP) on behalf of long-term stockholders following a class action complaint that was filed against Inspire Medical on December 22, 2023 with a Class Period from May 3, 2023 to November 7, 2023. Our investigation concerns whether the board of directors of Inspire Medical have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · February 21, 2024
INSP DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via NewMediaWire · February 20, 2024
INSP DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Via TheNewswire.com · February 20, 2024

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP), if they purchased the Company’s shares between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Minnesota.
By Kahn Swick & Foti, LLC · Via Business Wire · February 16, 2024

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 20, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
By The Law Offices of Frank R. Cruz · Via Business Wire · February 16, 2024